Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy

Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy

US Patent 9364494 · Granted Jun 14, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine ind2023
Cyclic dinucleotides for cytokine induction2023
Cyclic dinucleotides for cytokine induction2023
Cyclic dinucleotides for cytokine induction2021
Cyclic dinucleotides for cytokine induction2021
Methods for predicting pancreatic cancer treatment response2020
Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a 2020
Cyclic dinucleotides for cytokine induction2020
Cyclic dinucleotides for cytokine induction2020
Cyclic dinucleotides for cytokine induction2018
Cyclic dinucleotides for cytokine induction2018
Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a mo2017